RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
+7.85%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.76B
AUM Growth
+$1.76B
(+0.1%)
Cap. Flow
-$67.8M
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$13.2M |
| 2 |
Eventbrite
EB
|
$11.8M |
| 3 |
Establishment Labs
ESTA
|
$9.29M |
| 4 |
PROS Holdings
PRO
|
$7.79M |
| 5 |
Pacira BioSciences
PCRX
|
$6.54M |
Top Sells
| 1 |
Semtech
SMTC
|
$13.7M |
| 2 |
Medifast
MED
|
$11.8M |
| 3 |
Premier
PINC
|
$10.7M |
| 4 |
Medpace
MEDP
|
$8.27M |
| 5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$6.5M |
Sector Composition
| 1 | Healthcare | 28.23% |
| 2 | Technology | 24.61% |
| 3 | Industrials | 19.11% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Communication Services | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
scPharmaceuticals
SCPH
$296M
| $813K | 0.05% |
+79,830
| New | +$813K |
|
227
Dolby
DLB
$6.94B
| $794K | 0.05% |
9,493
-10,000
| -51% | -$837K |
|
228
Devon Energy
DVN
$22.3B
| $793K | 0.05% |
16,402
-8,538
| -34% | -$413K |
|
229
Kirby Corp
KEX
$4.95B
| $790K | 0.04% |
10,268
-10,035
| -49% | -$772K |
|
230
UroGen Pharma
URGN
$896M
| $788K | 0.04% |
76,087
+2,882
| +4% | +$29.8K |
|
231
IDEX
IEX
$12.1B
| $763K | 0.04% |
3,546
-3,364
| -49% | -$724K |
|
232
Inotiv
NOTV
$54.3M
| $739K | 0.04% |
154,979
+6,525
| +4% | +$31.1K |
|
233
Exelixis
EXEL
$9.95B
| $736K | 0.04% |
38,519
-41,183
| -52% | -$787K |
|
234
Ciena
CIEN
$13.4B
| $697K | 0.04% |
16,397
-15,045
| -48% | -$639K |
|
235
AbbVie
ABBV
$374B
| $658K | 0.04% |
4,886
-75
| -2% | -$10.1K |
|
236
Y-mAbs Therapeutics
YMAB
$390M
| $632K | 0.04% |
93,022
+3,542
| +4% | +$24.1K |
|
237
Teledyne Technologies
TDY
$25.5B
| $597K | 0.03% |
1,453
-886
| -38% | -$364K |
|
238
Chevron
CVX
$318B
| $588K | 0.03% |
3,737
| – | – |
|
239
CDW
CDW
$21.4B
| $582K | 0.03% |
3,173
-3,562
| -53% | -$654K |
|
240
Abbott
ABT
$230B
| $576K | 0.03% |
5,286
-100
| -2% | -$10.9K |
|
241
Crane NXT
CXT
$3.49B
| $549K | 0.03% |
9,727
-41,349
| -81% | -$2.33M |
|
242
Apple
AAPL
$3.54T
| $543K | 0.03% |
2,800
| – | – |
|
243
MP Materials
MP
$11.7B
| $523K | 0.03% |
22,858
-22,074
| -49% | -$505K |
|
244
Glacier Bancorp
GBCI
$5.79B
| $520K | 0.03% |
16,671
-10,000
| -37% | -$312K |
|
245
Berkshire Hathaway Class A
BRK.A
$1.08T
| $518K | 0.03% |
1
| – | – |
|
246
Jacobs Solutions
J
$17.1B
| $421K | 0.02% |
4,286
| – | – |
|
247
Sysco
SYY
$38.8B
| $412K | 0.02% |
5,552
-150
| -3% | -$11.1K |
|
248
Exxon Mobil
XOM
$477B
| $391K | 0.02% |
3,650
-93
| -2% | -$9.97K |
|
249
Scholar Rock
SRRK
$3.3B
| $361K | 0.02% |
47,822
+1,601
| +3% | +$12.1K |
|
250
Moody's
MCO
$89B
| $323K | 0.02% |
928
-43
| -4% | -$15K |
|